Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART by A.A. Okoye, Y. Fukazawa, B.E. Randall, R. Lum, B. Varco-Merth, S.D. Falcinelli, J. Smedley, R. Dunham, J.D. Lifson, L.J. Picker

Get full text

B cell depletion alone or in combination with IL-15 or PD-1 blockade facilitates enhanced control of virus replication in SIV-infected rhesus macaques by L.J. Picker, Y. Fukazawa, H. Behrns, B.E. Randall, B. Varco-Merth, H. Park, B.K. Felber, G.N. Pavlakis, J.D. Lifson, A.A. Okoye

Get full text

OP 2.5 – 00048 Targeting the SIV reservoir with Alemtuzumab by B. Varco-Merth, M. Chaunzwa, D. Duell, A. Marenco, S. Docken, J. Smedley, M.K. Axthelm, S.G. Hansen, M.P. Davenport, J.D. Estes, B. Keele, J.D. Lifson, S.R. Lewin, A.A. Okoye, L.J. Picker

Get full text

SIV persists in lymphoid tissues despite alemtuzumab-induced CD4+ T cell depletion by A.A. Okoye, S.R. Lewin, C.H. Xu, M. Vaidya, D.M. Duell, W.B. Brantley, M.A. Marenco, Y. Fukazawa, H.M. Park, T.A. Rasmussen, J.D. Lifson, M.K. Axthelm, S.G. Deeks, L.J. Picker

Get full text

PP 8.1 – 00003 Optimization of the 5′ cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ART by W. Omange, B. Varco-Merth, A. Morenco, M.T. Chaunzwa, C. Nkoy, D. Duell, O. Fadeyi, M. Medina, S. Hoffmeister, W. Goodwin, R. Butler, Z. Etaki, H. Park, J. Smedley, M.K. Axhelm, S. Hansen, J. Lifson, J. Gergen, S. Rauch, B. Petsch, L.J. Picker, A.A. Okoye

Get full text